EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Artificial Intelligence Empowers Regulatory Compliance Science for Medical Devices: From Premarket Approval to Post-market Surveillance, How Far Are We There?

Yu-Sheng Hsueh, Regis J. O’Keefe, Stuart Goodman, Péter Hegyi, R. Geoff Richards, Minghao Zheng, Wenxue Tong, Jiankun Xu, Christer Rolf, Patrick Shu-Hang Yung, Ling Qin

Engineering · 2026-10

DOI: 10.1016/j.eng.2026.10.012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Engineering, 2026-10. Verfasst von Yu-Sheng Hsueh und 10 weiteren Autor:innen. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University Grants Committee Research Grants Council, The Chinese University of Hong Kong.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

While artificial intelligence (AI) in medicine has been extensively studied as a medical device, its role as a governance tool for regulatory authorities remains largely unexplored. The rapid influx of innovative, AI-integrated medical devices has revealed critical bottlenecks in the current human-designed regulatory system (Hud-RS), including approval delays and resource constraints. In this work, we conceptualize a comprehensive dynamic framework for regulatory modernization, termed the “Artificial Intelligence Governance Regulatory System (Aig-RS).” The framework covers the full product lifecycle, from pre-clinical and clinical review to post-market surveillance. We examine current practices across regulatory agencies and propose strategies to optimize existing measures to streamline review processes. Although the US Food and Drug Administration (FDA) has made significant advances with its agency-wide tool (enterprise language support assistant (ELSA)), timely translation of innovative medical devices into clinical practice remains limited. Accordingly, Aig-RS is intended to accelerate regulatory decision-making safely by leveraging AI and to clarify how regulatory agencies can implement AI across the review continuum.

Förderung

  • University Grants Committee Research Grants Council
  • The Chinese University of Hong Kong

Zitieren

APA

Hsueh, Y., O’Keefe, R. J., Goodman, S., Hegyi, P., Richards, R. G., Zheng, M., Tong, W., Xu, J., Rolf, C., Yung, P. S., & Qin, L. (2026). Artificial Intelligence Empowers Regulatory Compliance Science for Medical Devices: From Premarket Approval to Post-market Surveillance, How Far Are We There?. Engineering. https://doi.org/10.1016/j.eng.2026.10.012

Vancouver

Hsueh Y, O’Keefe RJ, Goodman S, Hegyi P, Richards RG, Zheng M, et al. Artificial Intelligence Empowers Regulatory Compliance Science for Medical Devices: From Premarket Approval to Post-market Surveillance, How Far Are We There?. Engineering. 2026. doi:10.1016/j.eng.2026.10.012

BibTeX
@article{Hsueh2026,
  author = {Hsueh, Yu-Sheng and O’Keefe, Regis J. and Goodman, Stuart and Hegyi, Péter and Richards, R. Geoff and Zheng, Minghao and Tong, Wenxue and Xu, Jiankun and Rolf, Christer and Yung, Patrick Shu-Hang and Qin, Ling},
  title = {Artificial Intelligence Empowers Regulatory Compliance Science for Medical Devices: From Premarket Approval to Post-market Surveillance, How Far Are We There?},
  journal = {Engineering},
  year = {2026},
  doi = {10.1016/j.eng.2026.10.012}
}
Kostenlos starten →